Latest Recapitalisation News

Austral Resources Australia Ltd has launched a $40 million placement at 5 cents per share to fund the acquisition and recommissioning of the Rocklands copper project in Queensland. The offer includes share and option issues tied to debt conversions and is conditional on shareholder approval and ASX reinstatement.

Keybridge Capital has secured an extension of its bridge funding facility with WAM Active until late November 2025, maintaining current terms to support its ongoing recapitalisation efforts.

Pure Foods Tasmania has completed a strongly oversubscribed $1.76 million capital raise and reported improved preliminary FY25 results, signaling progress in its turnaround strategy.

Elanor Investors Group advances its strategic alliance with Rockworth Capital Partners through a $125 million recapitalisation and Firmus acquisition, while rejecting an unsolicited takeover offer for its commercial property fund. The group also reports FY24 results highlighting stabilisation efforts amid high gearing.

Pure Foods Tasmania reported a 30% revenue decline in FY25 but improved its net loss through cost-cutting and product rationalisation. Post-year-end recapitalisation efforts aim to strengthen the balance sheet and support the turnaround.

Elanor Investors Group reported a substantial $157.8 million net loss for FY24 amid asset devaluations and debt covenant breaches, prompting a strategic recapitalisation and leadership transition.

Pure Foods Tasmania has secured a $400,000 investment from entrepreneurs Jon Kontopos and Matthew Abrahams as part of a broader $750,000 capital raising effort, reinforcing confidence in the company’s turnaround plan ahead of its upcoming shareholder vote.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its plant-based milks and dairy segments. The company has resolved legacy litigation issues and is now focused on navigating the $610 million convertible note maturity due in 2027.

AMA Group reported a robust FY25 with revenue surpassing $1 billion and a 38% jump in normalized EBITDA, underpinned by operational improvements and a strengthened balance sheet.

AMA Group Limited reported a robust FY25 with revenue climbing 8.6% to over $1 billion and a 38.4% jump in normalised EBITDA, while significantly reducing net debt following a major equity raise and debt refinancing.

Universal Biosensors Pty Limited has entered voluntary administration with KPMG appointed as administrators, signaling urgent financial distress and a potential restructuring ahead.

Genetic Technologies Limited has emerged from voluntary administration following a strategic asset sale and is now pursuing recapitalisation and acquisitions to restore its market position.